Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

October 01, 2000; Volume 28,Issue 10
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Achira, Meguru

    1. You have access
      Selective Inhibition of Human Cytochrome P450 3A4 byN-[2(R)-Hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by Valspodar in Gene Transfectant Systems
      Iichiro Kawahara, Yukio Kato, Hiroshi Suzuki, Meguru Achira, Kiyomi Ito, Charles L. Crespi and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2000, 28 (10) 1238-1243;
  2. Ammon, Susanne

    1. You have access
      In Vitro Interaction of Codeine and Diclofenac
      Susanne Ammon, Oliver von Richter, Ute Hofmann, Klaus-Peter Thon, Michel Eichelbaum and Gerd Mikus
      Drug Metabolism and Disposition October 2000, 28 (10) 1149-1152;
  3. Angus, Peter W.

    1. You have access
      Impaired Elimination of Propranolol Due to Right Heart Failure: Drug Clearance in the Isolated Liver and Its Relationship to Intrinsic Metabolic Capacity
      Connie Y. Ng, Hany Ghabrial, Denis J. Morgan, Michael S. Ching, Richard A. Smallwood and Peter W. Angus
      Drug Metabolism and Disposition October 2000, 28 (10) 1217-1221;

B

  1. Barone, Gary W.

    1. You have access
      Glucuronidation of Estrogens and Retinoic Acid and Expression of UDP-Glucuronosyltransferase 2B7 in Human Intestinal Mucosa
      Piotr J. Czernik, Joanna M. Little, Gary W. Barone, Jean-Pierre Raufman and Anna Radominska-Pandya
      Drug Metabolism and Disposition October 2000, 28 (10) 1210-1216;
  2. Barton, Paula T.

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;
  3. Boobis, Alan R.

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;
  4. Brouwer, Eric

    1. You have access
      Measurement of Fraction Unbound Paclitaxel in Human Plasma
      Eric Brouwer, Jaap Verweij, Peter De Bruijn, Walter J. Loos, Marrimuthoo Pillay, Dirk Buijs and Alex Sparreboom
      Drug Metabolism and Disposition October 2000, 28 (10) 1141-1145;
  5. Buijs, Dirk

    1. You have access
      Measurement of Fraction Unbound Paclitaxel in Human Plasma
      Eric Brouwer, Jaap Verweij, Peter De Bruijn, Walter J. Loos, Marrimuthoo Pillay, Dirk Buijs and Alex Sparreboom
      Drug Metabolism and Disposition October 2000, 28 (10) 1141-1145;

C

  1. Ching, Michael S.

    1. You have access
      Impaired Elimination of Propranolol Due to Right Heart Failure: Drug Clearance in the Isolated Liver and Its Relationship to Intrinsic Metabolic Capacity
      Connie Y. Ng, Hany Ghabrial, Denis J. Morgan, Michael S. Ching, Richard A. Smallwood and Peter W. Angus
      Drug Metabolism and Disposition October 2000, 28 (10) 1217-1221;
  2. Collier, Abby C.

    1. You have access
      A Highly Sensitive Fluorescent Microplate Method for the Determination of UDP-Glucuronosyl Transferase Activity in Tissues and Placental Cell Lines
      Abby C. Collier, Malcolm D. Tingle, Jeffrey A. Keelan, James W. Paxton and Murray D. Mitchell
      Drug Metabolism and Disposition October 2000, 28 (10) 1184-1186;
  3. Court, Michael H.

    1. You have access
      CYP2B6 Mediates the In Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants
      Leah M. Hesse, Karthik Venkatakrishnan, Michael H. Court, Lisa L. von Moltke, Su X. Duan, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1176-1183;
  4. Crespi, Charles L.

    1. You have access
      Selective Inhibition of Human Cytochrome P450 3A4 byN-[2(R)-Hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by Valspodar in Gene Transfectant Systems
      Iichiro Kawahara, Yukio Kato, Hiroshi Suzuki, Meguru Achira, Kiyomi Ito, Charles L. Crespi and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2000, 28 (10) 1238-1243;
  5. Czernik, Piotr J.

    1. You have access
      Glucuronidation of Estrogens and Retinoic Acid and Expression of UDP-Glucuronosyltransferase 2B7 in Human Intestinal Mucosa
      Piotr J. Czernik, Joanna M. Little, Gary W. Barone, Jean-Pierre Raufman and Anna Radominska-Pandya
      Drug Metabolism and Disposition October 2000, 28 (10) 1210-1216;

D

  1. Dean, Dennis C.

    1. You have access
      The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
      Rita A. Halpin, Leslie A. Geer, Kanyin E. Zhang, Tina M. Marks, Dennis C. Dean, Allen N. Jones, David Melillo, George Doss and Kamlesh P. Vyas
      Drug Metabolism and Disposition October 2000, 28 (10) 1244-1254;
  2. De Bruijn, Peter

    1. You have access
      Measurement of Fraction Unbound Paclitaxel in Human Plasma
      Eric Brouwer, Jaap Verweij, Peter De Bruijn, Walter J. Loos, Marrimuthoo Pillay, Dirk Buijs and Alex Sparreboom
      Drug Metabolism and Disposition October 2000, 28 (10) 1141-1145;
  3. Doss, George

    1. You have access
      The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
      Rita A. Halpin, Leslie A. Geer, Kanyin E. Zhang, Tina M. Marks, Dennis C. Dean, Allen N. Jones, David Melillo, George Doss and Kamlesh P. Vyas
      Drug Metabolism and Disposition October 2000, 28 (10) 1244-1254;
  4. Douya, Rika

    1. You have access
      The Involvement of Flavin-Containing Monooxygenase but Not CYP3A4 in Metabolism of Itopride Hydrochloride, a Gastroprokinetic Agent: Comparison with Cisapride and Mosapride Citrate
      Taisei Mushiroda, Rika Douya, Eiji Takahara and Osamu Nagata
      Drug Metabolism and Disposition October 2000, 28 (10) 1231-1237;
  5. Duan, Su X.

    1. You have access
      CYP2B6 Mediates the In Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants
      Leah M. Hesse, Karthik Venkatakrishnan, Michael H. Court, Lisa L. von Moltke, Su X. Duan, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1176-1183;
  6. Dvorchik, Barry H.

    1. You have access
      Disposition and Toxicity of a Mixed Backbone Antisense Oligonucleotide, Targeted against Human Cytomegalovirus, after Intravitreal Injection of Escalating Single Doses in the Rabbit
      Barry H. Dvorchik and Judith K. Marquis
      Drug Metabolism and Disposition October 2000, 28 (10) 1255-1261;

E

  1. Edwards, Robert J.

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;
  2. Eichelbaum, Michel

    1. You have access
      In Vitro Interaction of Codeine and Diclofenac
      Susanne Ammon, Oliver von Richter, Ute Hofmann, Klaus-Peter Thon, Michel Eichelbaum and Gerd Mikus
      Drug Metabolism and Disposition October 2000, 28 (10) 1149-1152;
  3. Ekins, Sean

    1. You have access
      (R)-, (S)-, and Racemic Fluoxetine N-Demethylation by Human Cytochrome P450 Enzymes
      Jeannine M. Margolis, John P. O'Donnell, Dayna C. Mankowski, Sean Ekins and R. Scott Obach
      Drug Metabolism and Disposition October 2000, 28 (10) 1187-1191;

F

  1. Faucette, Stephanie R.

    1. You have access
      Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity
      Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
      Drug Metabolism and Disposition October 2000, 28 (10) 1222-1230;

G

  1. Galchev, Vladimir

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;
  2. Geer, Leslie A.

    1. You have access
      The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
      Rita A. Halpin, Leslie A. Geer, Kanyin E. Zhang, Tina M. Marks, Dennis C. Dean, Allen N. Jones, David Melillo, George Doss and Kamlesh P. Vyas
      Drug Metabolism and Disposition October 2000, 28 (10) 1244-1254;
  3. Ghabrial, Hany

    1. You have access
      Impaired Elimination of Propranolol Due to Right Heart Failure: Drug Clearance in the Isolated Liver and Its Relationship to Intrinsic Metabolic Capacity
      Connie Y. Ng, Hany Ghabrial, Denis J. Morgan, Michael S. Ching, Richard A. Smallwood and Peter W. Angus
      Drug Metabolism and Disposition October 2000, 28 (10) 1217-1221;
  4. Greenblatt, David J.

    1. You have access
      Metabolism of the Antidepressant Mirtazapine In Vitro: Contribution of Cytochromes P-450 1A2, 2D6, and 3A4
      Elke Störmer, Lisa L. von Moltke, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1168-1175;
    2. You have access
      CYP2B6 Mediates the In Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants
      Leah M. Hesse, Karthik Venkatakrishnan, Michael H. Court, Lisa L. von Moltke, Su X. Duan, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1176-1183;
  5. Guyonnet, Isabelle

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;

H

  1. Halpin, Rita A.

    1. You have access
      The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
      Rita A. Halpin, Leslie A. Geer, Kanyin E. Zhang, Tina M. Marks, Dennis C. Dean, Allen N. Jones, David Melillo, George Doss and Kamlesh P. Vyas
      Drug Metabolism and Disposition October 2000, 28 (10) 1244-1254;
  2. Hawke, Roy L.

    1. You have access
      Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity
      Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
      Drug Metabolism and Disposition October 2000, 28 (10) 1222-1230;
  3. Hesse, Leah M.

    1. You have access
      CYP2B6 Mediates the In Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants
      Leah M. Hesse, Karthik Venkatakrishnan, Michael H. Court, Lisa L. von Moltke, Su X. Duan, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1176-1183;
  4. Hofmann, Ute

    1. You have access
      In Vitro Interaction of Codeine and Diclofenac
      Susanne Ammon, Oliver von Richter, Ute Hofmann, Klaus-Peter Thon, Michel Eichelbaum and Gerd Mikus
      Drug Metabolism and Disposition October 2000, 28 (10) 1149-1152;
  5. Hughes, Helen

    1. You have access
      In Vivo Metabolism and Mass Balance of 4-[4-Fluorophenoxy]benzaldehyde Semicarbazone in Rats
      Kumar Ramu, Gilbert N. Lam and Helen Hughes
      Drug Metabolism and Disposition October 2000, 28 (10) 1153-1161;

I

  1. Igarashi, Takashi

    1. You have access
      Both cMOAT/MRP2 and Another Unknown Transporter(s) Are Responsible for the Biliary Excretion of Glucuronide Conjugate of the Nonpeptide Angiotensin II Antagonist, Telmisaltan
      Yukio Kato, Takashi Igarashi, Yuichi Sugiyama and Akiko Nishino
      Drug Metabolism and Disposition October 2000, 28 (10) 1146-1148;
  2. Ikeda, Kazumasa

    1. You have access
      Tissue Distribution and Biotransformation of Potassium Oxonate after Oral Administration of a Novel Antitumor Agent (Drug Combination of Tegafur, 5-Chloro-2,4-dihydroxypyridine, and Potassium Oxonate) to Rats
      Kunihiro Yoshisue, Hirotoshi Masuda, Eiji Matsushima, Kazumasa Ikeda, Sekio Nagayama and Yasuro Kawaguchi
      Drug Metabolism and Disposition October 2000, 28 (10) 1162-1167;
  3. Ito, Kiyomi

    1. You have access
      Selective Inhibition of Human Cytochrome P450 3A4 byN-[2(R)-Hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by Valspodar in Gene Transfectant Systems
      Iichiro Kawahara, Yukio Kato, Hiroshi Suzuki, Meguru Achira, Kiyomi Ito, Charles L. Crespi and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2000, 28 (10) 1238-1243;

J

  1. Jones, Allen N.

    1. You have access
      The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
      Rita A. Halpin, Leslie A. Geer, Kanyin E. Zhang, Tina M. Marks, Dennis C. Dean, Allen N. Jones, David Melillo, George Doss and Kamlesh P. Vyas
      Drug Metabolism and Disposition October 2000, 28 (10) 1244-1254;

K

  1. Kato, Yukio

    1. You have access
      Both cMOAT/MRP2 and Another Unknown Transporter(s) Are Responsible for the Biliary Excretion of Glucuronide Conjugate of the Nonpeptide Angiotensin II Antagonist, Telmisaltan
      Yukio Kato, Takashi Igarashi, Yuichi Sugiyama and Akiko Nishino
      Drug Metabolism and Disposition October 2000, 28 (10) 1146-1148;
    2. You have access
      Selective Inhibition of Human Cytochrome P450 3A4 byN-[2(R)-Hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by Valspodar in Gene Transfectant Systems
      Iichiro Kawahara, Yukio Kato, Hiroshi Suzuki, Meguru Achira, Kiyomi Ito, Charles L. Crespi and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2000, 28 (10) 1238-1243;
  2. Kawaguchi, Yasuro

    1. You have access
      Tissue Distribution and Biotransformation of Potassium Oxonate after Oral Administration of a Novel Antitumor Agent (Drug Combination of Tegafur, 5-Chloro-2,4-dihydroxypyridine, and Potassium Oxonate) to Rats
      Kunihiro Yoshisue, Hirotoshi Masuda, Eiji Matsushima, Kazumasa Ikeda, Sekio Nagayama and Yasuro Kawaguchi
      Drug Metabolism and Disposition October 2000, 28 (10) 1162-1167;
  3. Kawahara, Iichiro

    1. You have access
      Selective Inhibition of Human Cytochrome P450 3A4 byN-[2(R)-Hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by Valspodar in Gene Transfectant Systems
      Iichiro Kawahara, Yukio Kato, Hiroshi Suzuki, Meguru Achira, Kiyomi Ito, Charles L. Crespi and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2000, 28 (10) 1238-1243;
  4. Keelan, Jeffrey A.

    1. You have access
      A Highly Sensitive Fluorescent Microplate Method for the Determination of UDP-Glucuronosyl Transferase Activity in Tissues and Placental Cell Lines
      Abby C. Collier, Malcolm D. Tingle, Jeffrey A. Keelan, James W. Paxton and Murray D. Mitchell
      Drug Metabolism and Disposition October 2000, 28 (10) 1184-1186;
  5. Kindt, Erick

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;
  6. Kostrubsky, Vsevolod E.

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;

L

  1. Laethem, Ronald M.

    1. You have access
      Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity
      Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
      Drug Metabolism and Disposition October 2000, 28 (10) 1222-1230;
  2. Lake, Brian G.

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;
  3. Lam, Gilbert N.

    1. You have access
      In Vivo Metabolism and Mass Balance of 4-[4-Fluorophenoxy]benzaldehyde Semicarbazone in Rats
      Kumar Ramu, Gilbert N. Lam and Helen Hughes
      Drug Metabolism and Disposition October 2000, 28 (10) 1153-1161;
  4. Lecluyse, Edward L.

    1. You have access
      Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity
      Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
      Drug Metabolism and Disposition October 2000, 28 (10) 1222-1230;
  5. Lindley, Celeste M.

    1. You have access
      Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity
      Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
      Drug Metabolism and Disposition October 2000, 28 (10) 1222-1230;
  6. Little, Joanna M.

    1. You have access
      Glucuronidation of Estrogens and Retinoic Acid and Expression of UDP-Glucuronosyltransferase 2B7 in Human Intestinal Mucosa
      Piotr J. Czernik, Joanna M. Little, Gary W. Barone, Jean-Pierre Raufman and Anna Radominska-Pandya
      Drug Metabolism and Disposition October 2000, 28 (10) 1210-1216;
  7. Loos, Walter J.

    1. You have access
      Measurement of Fraction Unbound Paclitaxel in Human Plasma
      Eric Brouwer, Jaap Verweij, Peter De Bruijn, Walter J. Loos, Marrimuthoo Pillay, Dirk Buijs and Alex Sparreboom
      Drug Metabolism and Disposition October 2000, 28 (10) 1141-1145;

M

  1. Mankowski, Dayna C.

    1. You have access
      (R)-, (S)-, and Racemic Fluoxetine N-Demethylation by Human Cytochrome P450 Enzymes
      Jeannine M. Margolis, John P. O'Donnell, Dayna C. Mankowski, Sean Ekins and R. Scott Obach
      Drug Metabolism and Disposition October 2000, 28 (10) 1187-1191;
  2. Margolis, Jeannine M.

    1. You have access
      (R)-, (S)-, and Racemic Fluoxetine N-Demethylation by Human Cytochrome P450 Enzymes
      Jeannine M. Margolis, John P. O'Donnell, Dayna C. Mankowski, Sean Ekins and R. Scott Obach
      Drug Metabolism and Disposition October 2000, 28 (10) 1187-1191;
  3. Marks, Tina M.

    1. You have access
      The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
      Rita A. Halpin, Leslie A. Geer, Kanyin E. Zhang, Tina M. Marks, Dennis C. Dean, Allen N. Jones, David Melillo, George Doss and Kamlesh P. Vyas
      Drug Metabolism and Disposition October 2000, 28 (10) 1244-1254;
  4. Marquis, Judith K.

    1. You have access
      Disposition and Toxicity of a Mixed Backbone Antisense Oligonucleotide, Targeted against Human Cytomegalovirus, after Intravitreal Injection of Escalating Single Doses in the Rabbit
      Barry H. Dvorchik and Judith K. Marquis
      Drug Metabolism and Disposition October 2000, 28 (10) 1255-1261;
  5. Masuda, Hirotoshi

    1. You have access
      Tissue Distribution and Biotransformation of Potassium Oxonate after Oral Administration of a Novel Antitumor Agent (Drug Combination of Tegafur, 5-Chloro-2,4-dihydroxypyridine, and Potassium Oxonate) to Rats
      Kunihiro Yoshisue, Hirotoshi Masuda, Eiji Matsushima, Kazumasa Ikeda, Sekio Nagayama and Yasuro Kawaguchi
      Drug Metabolism and Disposition October 2000, 28 (10) 1162-1167;
  6. Matsushima, Eiji

    1. You have access
      Tissue Distribution and Biotransformation of Potassium Oxonate after Oral Administration of a Novel Antitumor Agent (Drug Combination of Tegafur, 5-Chloro-2,4-dihydroxypyridine, and Potassium Oxonate) to Rats
      Kunihiro Yoshisue, Hirotoshi Masuda, Eiji Matsushima, Kazumasa Ikeda, Sekio Nagayama and Yasuro Kawaguchi
      Drug Metabolism and Disposition October 2000, 28 (10) 1162-1167;
  7. Melillo, David

    1. You have access
      The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
      Rita A. Halpin, Leslie A. Geer, Kanyin E. Zhang, Tina M. Marks, Dennis C. Dean, Allen N. Jones, David Melillo, George Doss and Kamlesh P. Vyas
      Drug Metabolism and Disposition October 2000, 28 (10) 1244-1254;
  8. Mikus, Gerd

    1. You have access
      In Vitro Interaction of Codeine and Diclofenac
      Susanne Ammon, Oliver von Richter, Ute Hofmann, Klaus-Peter Thon, Michel Eichelbaum and Gerd Mikus
      Drug Metabolism and Disposition October 2000, 28 (10) 1149-1152;
  9. Mitchell, Murray D.

    1. You have access
      A Highly Sensitive Fluorescent Microplate Method for the Determination of UDP-Glucuronosyl Transferase Activity in Tissues and Placental Cell Lines
      Abby C. Collier, Malcolm D. Tingle, Jeffrey A. Keelan, James W. Paxton and Murray D. Mitchell
      Drug Metabolism and Disposition October 2000, 28 (10) 1184-1186;
  10. Morgan, Denis J.

    1. You have access
      Impaired Elimination of Propranolol Due to Right Heart Failure: Drug Clearance in the Isolated Liver and Its Relationship to Intrinsic Metabolic Capacity
      Connie Y. Ng, Hany Ghabrial, Denis J. Morgan, Michael S. Ching, Richard A. Smallwood and Peter W. Angus
      Drug Metabolism and Disposition October 2000, 28 (10) 1217-1221;
  11. Mushiroda, Taisei

    1. You have access
      The Involvement of Flavin-Containing Monooxygenase but Not CYP3A4 in Metabolism of Itopride Hydrochloride, a Gastroprokinetic Agent: Comparison with Cisapride and Mosapride Citrate
      Taisei Mushiroda, Rika Douya, Eiji Takahara and Osamu Nagata
      Drug Metabolism and Disposition October 2000, 28 (10) 1231-1237;

N

  1. Nagata, Osamu

    1. You have access
      The Involvement of Flavin-Containing Monooxygenase but Not CYP3A4 in Metabolism of Itopride Hydrochloride, a Gastroprokinetic Agent: Comparison with Cisapride and Mosapride Citrate
      Taisei Mushiroda, Rika Douya, Eiji Takahara and Osamu Nagata
      Drug Metabolism and Disposition October 2000, 28 (10) 1231-1237;
  2. Nagayama, Sekio

    1. You have access
      Tissue Distribution and Biotransformation of Potassium Oxonate after Oral Administration of a Novel Antitumor Agent (Drug Combination of Tegafur, 5-Chloro-2,4-dihydroxypyridine, and Potassium Oxonate) to Rats
      Kunihiro Yoshisue, Hirotoshi Masuda, Eiji Matsushima, Kazumasa Ikeda, Sekio Nagayama and Yasuro Kawaguchi
      Drug Metabolism and Disposition October 2000, 28 (10) 1162-1167;
  3. Ng, Connie Y.

    1. You have access
      Impaired Elimination of Propranolol Due to Right Heart Failure: Drug Clearance in the Isolated Liver and Its Relationship to Intrinsic Metabolic Capacity
      Connie Y. Ng, Hany Ghabrial, Denis J. Morgan, Michael S. Ching, Richard A. Smallwood and Peter W. Angus
      Drug Metabolism and Disposition October 2000, 28 (10) 1217-1221;
  4. Nishino, Akiko

    1. You have access
      Both cMOAT/MRP2 and Another Unknown Transporter(s) Are Responsible for the Biliary Excretion of Glucuronide Conjugate of the Nonpeptide Angiotensin II Antagonist, Telmisaltan
      Yukio Kato, Takashi Igarashi, Yuichi Sugiyama and Akiko Nishino
      Drug Metabolism and Disposition October 2000, 28 (10) 1146-1148;

O

  1. O'Donnell, John P.

    1. You have access
      (R)-, (S)-, and Racemic Fluoxetine N-Demethylation by Human Cytochrome P450 Enzymes
      Jeannine M. Margolis, John P. O'Donnell, Dayna C. Mankowski, Sean Ekins and R. Scott Obach
      Drug Metabolism and Disposition October 2000, 28 (10) 1187-1191;
  2. Obach, R. Scott

    1. You have access
      (R)-, (S)-, and Racemic Fluoxetine N-Demethylation by Human Cytochrome P450 Enzymes
      Jeannine M. Margolis, John P. O'Donnell, Dayna C. Mankowski, Sean Ekins and R. Scott Obach
      Drug Metabolism and Disposition October 2000, 28 (10) 1187-1191;

P

  1. Paxton, James W.

    1. You have access
      A Highly Sensitive Fluorescent Microplate Method for the Determination of UDP-Glucuronosyl Transferase Activity in Tissues and Placental Cell Lines
      Abby C. Collier, Malcolm D. Tingle, Jeffrey A. Keelan, James W. Paxton and Murray D. Mitchell
      Drug Metabolism and Disposition October 2000, 28 (10) 1184-1186;
  2. Pelkonen, Olavi

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;
  3. Pillay, Marrimuthoo

    1. You have access
      Measurement of Fraction Unbound Paclitaxel in Human Plasma
      Eric Brouwer, Jaap Verweij, Peter De Bruijn, Walter J. Loos, Marrimuthoo Pillay, Dirk Buijs and Alex Sparreboom
      Drug Metabolism and Disposition October 2000, 28 (10) 1141-1145;
  4. Price, Roger J.

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;

R

  1. Radominska-Pandya, Anna

    1. You have access
      Glucuronidation of Estrogens and Retinoic Acid and Expression of UDP-Glucuronosyltransferase 2B7 in Human Intestinal Mucosa
      Piotr J. Czernik, Joanna M. Little, Gary W. Barone, Jean-Pierre Raufman and Anna Radominska-Pandya
      Drug Metabolism and Disposition October 2000, 28 (10) 1210-1216;
  2. Ramachandran, Vinod

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;
  3. Ramu, Kumar

    1. You have access
      In Vivo Metabolism and Mass Balance of 4-[4-Fluorophenoxy]benzaldehyde Semicarbazone in Rats
      Kumar Ramu, Gilbert N. Lam and Helen Hughes
      Drug Metabolism and Disposition October 2000, 28 (10) 1153-1161;
  4. Raufman, Jean-Pierre

    1. You have access
      Glucuronidation of Estrogens and Retinoic Acid and Expression of UDP-Glucuronosyltransferase 2B7 in Human Intestinal Mucosa
      Piotr J. Czernik, Joanna M. Little, Gary W. Barone, Jean-Pierre Raufman and Anna Radominska-Pandya
      Drug Metabolism and Disposition October 2000, 28 (10) 1210-1216;
  5. Renwick, Anthony B.

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;
  6. Rose, Kelly

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;

S

  1. Schrag, Michael L.

    1. You have access
      Topological Alteration of the CYP3A4 Active Site by the Divalent Cation Mg2+
      Michael L. Schrag and Larry C. Wienkers
      Drug Metabolism and Disposition October 2000, 28 (10) 1198-1201;
  2. Shader, Richard I.

    1. You have access
      Metabolism of the Antidepressant Mirtazapine In Vitro: Contribution of Cytochromes P-450 1A2, 2D6, and 3A4
      Elke Störmer, Lisa L. von Moltke, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1168-1175;
    2. You have access
      CYP2B6 Mediates the In Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants
      Leah M. Hesse, Karthik Venkatakrishnan, Michael H. Court, Lisa L. von Moltke, Su X. Duan, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1176-1183;
  3. Shord, Stacy S.

    1. You have access
      Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity
      Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
      Drug Metabolism and Disposition October 2000, 28 (10) 1222-1230;
  4. Sinclair, Jacqueline F.

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;
  5. Sinz, Michael

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;
  6. Smallwood, Richard A.

    1. You have access
      Impaired Elimination of Propranolol Due to Right Heart Failure: Drug Clearance in the Isolated Liver and Its Relationship to Intrinsic Metabolic Capacity
      Connie Y. Ng, Hany Ghabrial, Denis J. Morgan, Michael S. Ching, Richard A. Smallwood and Peter W. Angus
      Drug Metabolism and Disposition October 2000, 28 (10) 1217-1221;
  7. Sparreboom, Alex

    1. You have access
      Measurement of Fraction Unbound Paclitaxel in Human Plasma
      Eric Brouwer, Jaap Verweij, Peter De Bruijn, Walter J. Loos, Marrimuthoo Pillay, Dirk Buijs and Alex Sparreboom
      Drug Metabolism and Disposition October 2000, 28 (10) 1141-1145;
  8. Störmer, Elke

    1. You have access
      Metabolism of the Antidepressant Mirtazapine In Vitro: Contribution of Cytochromes P-450 1A2, 2D6, and 3A4
      Elke Störmer, Lisa L. von Moltke, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1168-1175;
  9. Strom, Stephen C.

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;
  10. Sugiyama, Yuichi

    1. You have access
      Both cMOAT/MRP2 and Another Unknown Transporter(s) Are Responsible for the Biliary Excretion of Glucuronide Conjugate of the Nonpeptide Angiotensin II Antagonist, Telmisaltan
      Yukio Kato, Takashi Igarashi, Yuichi Sugiyama and Akiko Nishino
      Drug Metabolism and Disposition October 2000, 28 (10) 1146-1148;
    2. You have access
      Selective Inhibition of Human Cytochrome P450 3A4 byN-[2(R)-Hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by Valspodar in Gene Transfectant Systems
      Iichiro Kawahara, Yukio Kato, Hiroshi Suzuki, Meguru Achira, Kiyomi Ito, Charles L. Crespi and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2000, 28 (10) 1238-1243;
  11. Suzuki, Hiroshi

    1. You have access
      Selective Inhibition of Human Cytochrome P450 3A4 byN-[2(R)-Hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by Valspodar in Gene Transfectant Systems
      Iichiro Kawahara, Yukio Kato, Hiroshi Suzuki, Meguru Achira, Kiyomi Ito, Charles L. Crespi and Yuichi Sugiyama
      Drug Metabolism and Disposition October 2000, 28 (10) 1238-1243;

T

  1. Takahara, Eiji

    1. You have access
      The Involvement of Flavin-Containing Monooxygenase but Not CYP3A4 in Metabolism of Itopride Hydrochloride, a Gastroprokinetic Agent: Comparison with Cisapride and Mosapride Citrate
      Taisei Mushiroda, Rika Douya, Eiji Takahara and Osamu Nagata
      Drug Metabolism and Disposition October 2000, 28 (10) 1231-1237;
  2. Thon, Klaus-Peter

    1. You have access
      In Vitro Interaction of Codeine and Diclofenac
      Susanne Ammon, Oliver von Richter, Ute Hofmann, Klaus-Peter Thon, Michel Eichelbaum and Gerd Mikus
      Drug Metabolism and Disposition October 2000, 28 (10) 1149-1152;
  3. Tingle, Malcolm D.

    1. You have access
      A Highly Sensitive Fluorescent Microplate Method for the Determination of UDP-Glucuronosyl Transferase Activity in Tissues and Placental Cell Lines
      Abby C. Collier, Malcolm D. Tingle, Jeffrey A. Keelan, James W. Paxton and Murray D. Mitchell
      Drug Metabolism and Disposition October 2000, 28 (10) 1184-1186;
  4. Tredger, J. Michael

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;

V

  1. Venkatakrishnan, Karthik

    1. You have access
      CYP2B6 Mediates the In Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants
      Leah M. Hesse, Karthik Venkatakrishnan, Michael H. Court, Lisa L. von Moltke, Su X. Duan, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1176-1183;
  2. Venkataramanan, Raman

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;
  3. Verweij, Jaap

    1. You have access
      Measurement of Fraction Unbound Paclitaxel in Human Plasma
      Eric Brouwer, Jaap Verweij, Peter De Bruijn, Walter J. Loos, Marrimuthoo Pillay, Dirk Buijs and Alex Sparreboom
      Drug Metabolism and Disposition October 2000, 28 (10) 1141-1145;
  4. von Moltke, Lisa L.

    1. You have access
      Metabolism of the Antidepressant Mirtazapine In Vitro: Contribution of Cytochromes P-450 1A2, 2D6, and 3A4
      Elke Störmer, Lisa L. von Moltke, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1168-1175;
    2. You have access
      CYP2B6 Mediates the In Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants
      Leah M. Hesse, Karthik Venkatakrishnan, Michael H. Court, Lisa L. von Moltke, Su X. Duan, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition October 2000, 28 (10) 1176-1183;
  5. von Richter, Oliver

    1. You have access
      In Vitro Interaction of Codeine and Diclofenac
      Susanne Ammon, Oliver von Richter, Ute Hofmann, Klaus-Peter Thon, Michel Eichelbaum and Gerd Mikus
      Drug Metabolism and Disposition October 2000, 28 (10) 1149-1152;
  6. Vyas, Kamlesh P.

    1. You have access
      The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
      Rita A. Halpin, Leslie A. Geer, Kanyin E. Zhang, Tina M. Marks, Dennis C. Dean, Allen N. Jones, David Melillo, George Doss and Kamlesh P. Vyas
      Drug Metabolism and Disposition October 2000, 28 (10) 1244-1254;

W

  1. Watts, Patricia S.

    1. You have access
      Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
      Anthony B. Renwick, Patricia S. Watts, Robert J. Edwards, Paula T. Barton, Isabelle Guyonnet, Roger J. Price, J. Michael Tredger, Olavi Pelkonen, Alan R. Boobis and Brian G. Lake
      Drug Metabolism and Disposition October 2000, 28 (10) 1202-1209;
  2. Wen, Yuan Hua

    1. You have access
      The Role of Conjugation in Hepatotoxicity of Troglitazone in Human and Porcine Hepatocyte Cultures
      Vsevolod E. Kostrubsky, Jacqueline F. Sinclair, Vinod Ramachandran, Raman Venkataramanan, Yuan Hua Wen, Erick Kindt, Vladimir Galchev, Kelly Rose, Michael Sinz and Stephen C. Strom
      Drug Metabolism and Disposition October 2000, 28 (10) 1192-1197;
  3. Wienkers, Larry C.

    1. You have access
      Topological Alteration of the CYP3A4 Active Site by the Divalent Cation Mg2+
      Michael L. Schrag and Larry C. Wienkers
      Drug Metabolism and Disposition October 2000, 28 (10) 1198-1201;

Y

  1. Yan, Bingfang

    1. You have access
      Validation of Bupropion Hydroxylation as a Selective Marker of Human Cytochrome P450 2B6 Catalytic Activity
      Stephanie R. Faucette, Roy L. Hawke, Edward L. Lecluyse, Stacy S. Shord, Bingfang Yan, Ronald M. Laethem and Celeste M. Lindley
      Drug Metabolism and Disposition October 2000, 28 (10) 1222-1230;
  2. Yoshisue, Kunihiro

    1. You have access
      Tissue Distribution and Biotransformation of Potassium Oxonate after Oral Administration of a Novel Antitumor Agent (Drug Combination of Tegafur, 5-Chloro-2,4-dihydroxypyridine, and Potassium Oxonate) to Rats
      Kunihiro Yoshisue, Hirotoshi Masuda, Eiji Matsushima, Kazumasa Ikeda, Sekio Nagayama and Yasuro Kawaguchi
      Drug Metabolism and Disposition October 2000, 28 (10) 1162-1167;

Z

  1. Zhang, Kanyin E.

    1. You have access
      The Absorption, Distribution, Metabolism and Excretion of Rofecoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Rats and Dogs
      Rita A. Halpin, Leslie A. Geer, Kanyin E. Zhang, Tina M. Marks, Dennis C. Dean, Allen N. Jones, David Melillo, George Doss and Kamlesh P. Vyas
      Drug Metabolism and Disposition October 2000, 28 (10) 1244-1254;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 28 (10)
Drug Metabolism and Disposition
Vol. 28, Issue 10
1 Oct 2000
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Switch from CAR to PXR in the Presence of EGF
  • Alternative P450 Splicing Redirects Human Drug Metabolism
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics